Chembio shares slump as FDA revokes emergency use of COVID-19 test
Shares of Chembio Diagnostics Inc slumped more than 60% on Wednesday after the U.S. Food and Drug Administration (FDA) revoked the emergency use authorization for its COVID-19 antibody test kit on concerns about its accuracy. [Source]
Publication Date:Origin: reuters.com
Category: healthNews
Topics: COVID-19, emergency, Chembio, accuracy, concerns, antibody, authorization, revoked, (FDA), Administration, slumped, Diagnostics, Shares, revokes, slump, shares